About Ergomed
At PrimeVigilance, we are at the forefront of revolutionizing global drug safety and pharmacovigilance through pioneering technology and scientific expertise. Established in 2008 by the visionary founders Dr. Miroslav Reljanović and Dr. Elliot Brown, our company has consistently pushed the boundaries of what's possible in ensuring the safety of pharmaceutical, biotechnology, and medical device products. Our core mission is to create a world with safer drugs, and we achieve this by integrating deep medical and scientific knowledge with cutting-edge regulatory science. This innovative approach allows us to identify previously unrecognized adverse effects and evolving patterns, enabling us to take decisive action to optimize the safe and effective use of medicines and medical devices for patients worldwide. Through our proprietary technology, the Automated Smart Processing PV Platform (ASaPPV), we are transforming the landscape of adverse event intake and processing. This platform automates critical steps, ensuring a standardized, repeatable, and fully audited process that enhances efficiency, quality, and productivity by minimizing manual intervention and standardizing data.
Our commitment to innovation extends beyond our proprietary systems. We leverage a sophisticated tech stack that includes best-in-class solutions like Oracle Argus for safety databases, alongside a suite of tools such as SmartRecruiters for talent acquisition and various data management and workflow systems to ensure seamless operations. This technological infrastructure, combined with our team of over 1,300 professionals across Europe, North America, and Asia, positions us as a leader in the field. Our experts, including former senior regulators and industry consultants, provide an unrivaled level of insight and guidance. We offer a comprehensive suite of services, from clinical trial safety and post-marketing surveillance to medical information and regulatory affairs. By offering adaptable business models and integrative project management, we provide our clients with flexible, cost-effective, and high-quality solutions that safeguard their assets and, most importantly, protect public health. PrimeVigilance is not just a service provider; we are a strategic partner dedicated to advancing the science of drug safety and shaping a healthier future.
FAQs
- When was Ergomed founded?
- Ergomed was founded in 2008.
- Who is the CEO of Ergomed?
- The CEOs are Dr. Miroslav Reljanović, Dr. Elliot Brown.
- What industries or markets does Ergomed operate in?
- Ergomed operates in the following markets: Pharmaceutical, Pharmacovigilance, Drug Safety, Biotechnology, Medical Devices, Regulatory Affairs, Clinical Trials, Healthcare Technology, Life Sciences, and Health Data Management.
- How many employees does Ergomed have?
- Ergomed has 1001-5000 employees.
- Where does Ergomed have employees?
- Ergomed has employees in United Kingdom.
- Does Ergomed support remote work or working from home?
- Yes, Ergomed is a remote-friendly company.
- What employee benefits does Ergomed offer?
- Ergomed provides 3 benefits to their employees.
- Does Ergomed offer a four-day work week?
- No, Ergomed does not offer a four-day work week.
- What is Ergomed's tech stack?
- Ergomed has 3 technologies in their tech stack.
- What is Ergomed's website?
- Ergomed's website is primevigilance.com.
